- Home
- ZONE vs PULM Comparison
ZONE vs PULM Comparison
Compare ZONE & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZONE
- PULM
- Stock Information
- Founded
- ZONE 2022
- PULM 2003
- Country
- ZONE United States
- PULM United States
- Employees
- ZONE N/A
- PULM N/A
- Industry
- ZONE
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- ZONE
- PULM Health Care
- Exchange
- ZONE NYSE
- PULM Nasdaq
- Market Cap
- ZONE 19.3M
- PULM 33.2M
- IPO Year
- ZONE 2024
- PULM N/A
- Fundamental
- Price
- ZONE $3.11
- PULM $6.21
- Analyst Decision
- ZONE
- PULM
- Analyst Count
- ZONE 0
- PULM 0
- Target Price
- ZONE N/A
- PULM N/A
- AVG Volume (30 Days)
- ZONE 62.3K
- PULM 55.4K
- Earning Date
- ZONE 05-14-2025
- PULM 08-12-2025
- Dividend Yield
- ZONE N/A
- PULM N/A
- EPS Growth
- ZONE N/A
- PULM N/A
- EPS
- ZONE N/A
- PULM N/A
- Revenue
- ZONE $1,887,046.00
- PULM $1,921,000.00
- Revenue This Year
- ZONE N/A
- PULM N/A
- Revenue Next Year
- ZONE N/A
- PULM $134.88
- P/E Ratio
- ZONE N/A
- PULM N/A
- Revenue Growth
- ZONE 38.12
- PULM N/A
- 52 Week Low
- ZONE $0.81
- PULM $1.78
- 52 Week High
- ZONE $5.54
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- ZONE N/A
- PULM 41.32
- Support Level
- ZONE N/A
- PULM $6.10
- Resistance Level
- ZONE N/A
- PULM $6.83
- Average True Range (ATR)
- ZONE 0.00
- PULM 0.33
- MACD
- ZONE 0.00
- PULM -0.05
- Stochastic Oscillator
- ZONE 0.00
- PULM 21.00
About ZONE CLEANCORE SOLUTIONS INC
CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).